# Transplantation Group

> **NIH NIH UM2** · RHO FEDERAL SYSTEMS DIVISION, INC. · 2021 · $1,698,563

## Abstract

PROJECT SUMMARY/ABSTRACT—TRANSPLANTATION GROUP 
 Through this Funding Opportunity Announcement, the NIAID Division of Allergy, Immunology and 
Transplantation (DAIT) intends to consolidate its funding for multiple, independent coordinating centers into a 
single, multi-component cooperative agreement in order to reduce costs and increase efficiency and 
standardization across research consortia. This new program will fund a single Center to support DAIT 
research in the areas of asthma and allergic diseases, autoimmune diseases, and transplantation. In the area 
of solid organ transplantation, the Center will support 4 consortia: Clinical Trials in Organ Transplantation 
(CTOT), Clinical Trials in Organ Transplantation in Children (CTOT-C), Genomics of Transplantation 
Cooperative Research Program (GTCRP), and the organ transplantation component of the Immune Tolerance 
Network (ITN). Within the Center, support for these 4 consortia will be organized under 1 group, the 
Transplantation Group (TG). The objective of the TG is to provide excellent and efficient study coordination 
support services across the transplant research consortia. To accomplish this objective, RhoFED aims to (1) 
provide staff experienced in transplantation research conducted by DAIT-supported consortia and to organize 
these staff in an administrative structure that manages resources efficiently, be responsive to the needs of the 
research consortia and DAIT, and facilitate communication and collaboration; (2) provide experienced 
scientists and statisticians who, in collaboration with clinical investigators and senior DAIT officials, will design 
and analyze studies across the full scope of research in transplantation; (3) facilitate the development, review, 
and revision of initial and successive drafts of protocols and protocol-related documents through dedicated TG 
protocol teams; and (4) provide study initiation and study management functions that are required for the 
efficient and ethical conduct of studies. Because RhoFED is currently the Statistical and Clinical Coordinating 
Center (SACCC) for the CTOT, CTOT-C and GTCRP consortia and is the Statistical Data Coordinating Center 
(SDCC) for ITN, Rho is uniquely well-qualified to provide consolidated Center support across these consortia. 
By providing staff with experience in supporting transplantation research, an administrative infrastructure 
designed to enhance collaboration between DAIT Project Officers and the consortia investigators, and a plan 
for agile and effective resource management, we believe that support of these consortia through the newly 
formed Center and its TG will directly contribute to the achievement of the DAIT objective to improve clinical 
outcomes following solid organ transplantation.

## Key facts

- **NIH application ID:** 10150751
- **Project number:** 5UM2AI117870-07
- **Recipient organization:** RHO FEDERAL SYSTEMS DIVISION, INC.
- **Principal Investigator:** Michelle Lynn Sever
- **Activity code:** UM2 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $1,698,563
- **Award type:** 5
- **Project period:** 2020-05-01 → 2022-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10150751

## Citation

> US National Institutes of Health, RePORTER application 10150751, Transplantation Group (5UM2AI117870-07). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10150751. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*